Article ID Journal Published Year Pages File Type
6241883 Respiratory Medicine 2013 11 Pages PDF
Abstract
The results from eXpeRience indicate that omalizumab was associated with improvements in outcomes in patients with uncontrolled persistent allergic asthma; these improvements were consistent with the results of clinical trials.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Preview
The eXpeRience registry: The 'real-world' effectiveness of omalizumab in allergic asthma
Authors
, , , , , ,